Janet L. Martin
Hormones and Cancer Group
Kolling Institute of Medical Research
University of Sydney
Royal North Shore Hospital
Australia
Name/email consistency: high
- Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. Martin, J.L., Lin, M.Z., McGowan, E.M., Baxter, R.C. J. Biol. Chem. (2009)
- Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Martin, J.L., Baxter, R.C. Endocrinology (2007)
- Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Martin, J.L., Jambazov, S. Endocrinology (2006)
- Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. Martin, J.L., Weenink, S.M., Baxter, R.C. J. Biol. Chem. (2003)
- Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Martin, J.L., Pattison, S.L. Endocrinology (2000)
- Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. Martin, J.L., Baxter, R.C. J. Biol. Chem. (1999)
